Home > Insider Trading > Filing (0000885590-11-000010)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
885590	Valeant Pharmaceuticals International Inc.	VRX	Pharmaceutical Preparations (2834)	000000000

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1343811	Ann Norma Provencio	7150 Mississauga Road Mississauga A6 L5N 8M5		Yes	No	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock, No Par Value	Acquisiton	2011-03-04	1,000	$39.87	117,404	No	4	P	Direct
Common Stock, No Par Value	Acquisiton	2011-03-04	195	$39.88	117,599	No	4	P	Direct
Common Stock, No Par Value	Acquisiton	2011-03-04	380	$39.88	117,979	No	4	P	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	P	Direct
No	4	P	Direct
No	4	P	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock, No Par Value	Deferred Share Units	Acquisiton	2011-03-05	2,517	$0.00	2,517	$0.00

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
2,517			No	4	A	Direct

Footnotes

Common stock held in the reporting person's 401k account.
Includes 102,353 Restricted Share Units ("RSUs") held by the reporting person as compensation for her services on the Board of Directors of the issuer, including 3,423 RSUs received as dividend equivalents as a result of a dividend paid on the common stock, no par value, of Valeant Pharmaceuticals International, Inc. on December 22, 2010.
Common stock held in the reporting person's IRA.
Each Deferred Share Unit entitles its holder, upon ceasing to be a director, to receive an amount of cash having the same value as one share of common sock, no par value of Valeant Pharmaceuticals International, Inc., at such time.